Dr. Sarah Elizabeth Griffin, MD

Dr. Griffin practices at University Medical Center New Orleans in New Orleans, Louisiana, part of LCMC Health.

Dr. Griffin's NPI, 1023404142, was assigned on April 15, 2015. Dr. Griffin holds Louisiana license 322125.

Dr. Griffin's primary practice is University Medical Center New Orleans, at 2000 Canal Street, New Orleans, LA 70112 in Orleans Parish. The practice phone is (504) 702-3000.

Dr. Griffin's primary practice is University Medical Center New Orleans in New Orleans, Louisiana, part of LCMC Health. Dr. Griffin is also affiliated with Lallie Kemp Regional Medical Center. The medical group on file is LSU Healthcare Network. Dmand AI also links Dr. Griffin to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Griffin practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Griffin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Griffin is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. Griffin is licensed in Louisiana.

CMS data shows 133 Medicare services from Dr. Griffin across 3 procedure codes in 2024, for 35 Medicare patients. Medicare paid $8,604 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 35 Medicare patients who saw Dr. Griffin in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 3.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Griffin's median patient age at 57, with 55% women.

In 2024, Dr. Griffin wrote 63 Medicare Part D claims for 18 patients. 89% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $63 in total drug cost. In 2020, CMS named 39 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Griffin for performance year 2024, reported as part of a group. Dr. Griffin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Griffin in 2015. Dr. Griffin's most frequent co-author is Marilyn J. Crain, MD.

CMS Open Payments shows 4 general payments to Dr. Griffin from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $36.